Correlation Engine 2.0
Clear Search sequence regions


  • antivirals (1)
  • donors (7)
  • hepacivirus (1)
  • human (9)
  • organ (2)
  • patients (1)
  • policy (1)
  • research (1)
  • south africa (1)
  • Sizes of these terms reflect their relevance to your search.

    A wide gap between the increasing demand for organs and the limited supply leads to immeasurable loss of life each year. The organ shortage could be attenuated by donors with human immunodeficiency virus (HIV) or hepatitis C virus (HCV). The transplantation of organs from HIV+ deceased donors into HIV+ individuals (HIV D+ /R+) was initiated in South Africa in 2010; however, this practice was forbidden in the USA until the HIV Organ Policy Equity (HOPE) Act in 2013. HIV D+/R+ transplantation is now practiced in the USA as part of ongoing research studies, helping to reduce waiting times for all patients on the waitlist. The introduction of direct acting antivirals for HCV has revolutionized the utilization of donors with HCV for HCV-uninfected (HCV-) recipients. This is particularly relevant as the HCV donor pool has increased substantially in the context of the rise in deaths related to drug overdose from injection drug use. This article serves to review the current literature on using organs from donors with HIV or HCV. © 2021. Société Internationale de Chirurgie.

    Citation

    Brian J Boyarsky, Alexandra T Strauss, Dorry L Segev. Transplanting Organs from Donors with HIV or Hepatitis C: The Viral Frontier. World journal of surgery. 2021 Dec;45(12):3503-3510

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33471156

    View Full Text